With the elimination of election uncertainty over the weekend, I knew there was going to be a rally today but had no idea it was going to be in the quadruple digits. Up over 1300 points as late as 2 pm, the Dow settled in the final two hours to still close a whopping 834 up. It was the double boost of the Biden victory combined with what was arguably even better news about some terrific promise on the vaccine front as Pfizer announced their new vaccine had tested very well and would be ready for distribution by the end of the year. With the worst case scenario suddenly now looking quite a bit less likely, buying soared, especially with all the traditional stocks that had been taking a beating during the pandemic. Conversely, the tech stocks that had been doing well during lockdown now took a hit as reflected in the Nasdaq diving 181 points. And the end of the day dive was only the result of McConnell saying that election investigations would continue. But the stocks hardest hit in the last nine months (i.e. airlines and cruise lines) all surged, Carnival up over 39 percent. The best news is that volume was enormous at 17.2 billion.
MON NOVEMBER 9, 2020 5:02 PM
Wall Street rallies on coronavirus
vaccine trial results
DJ: 28,323.40 -66.78 NAS: 11,895.23 +4.30 S&P: 3,509.44 -1.01 11/6
DJ: 29,157.97 +834.57 NAS: 11,713.78 -181.45 S&P: 3,550.50
+41.06 11/9
NEW
YORK (Reuters) - The S&P 500 and the Dow rallied sharply but closed shy of
their records on Monday as investors bet that a full economic reopening was
finally in sight following the first positive data from a late-stage COVID-19
vaccine trial. U.S. crude oil rose more
than 8% and pushed up energy stocks while safe-haven U.S. Treasuries sold off
after U.S. drugmaker Pfizer and its German partner BioNTech said a large-scale
trial of their vaccine showed it was more than 90% effective in preventing
COVID-19. Investors said they were also reassured by Saturday’s news that Joe
Biden had garnered enough votes to win the U.S. presidential election as they
had priced in this news last week.
“Election
uncertainty is fading into the rearview mirror. Now we have this boost of investor enthusiasm after the vaccine news,”
said to Michael Antonelli, market strategist at Baird in Milwaukee. “All the
types of companies that would benefit from us returning to a pre-COVID world
are the big winners today.” Sectors such
as energy, travel and financials which were among the hardest hit by lockdowns
aimed at curbing the virus were some of the biggest percentage gainers on
Monday. While their vaccine study is
still ongoing and requires approval, Pfizer and BioNTech said they had found no serious safety concerns so
far and expected to seek U.S. emergency use authorization later this month.
“It’s not that we’re out of the woods
with COVID. It’s that the vaccine
starts to remove the worst case scenario that we surge out of control
and go back into a national lockdown,” said Antonelli. “The market’s looking
into the future, to the first and second quarter of next year.”
However the S&P pared some gains late in
the session. U.S. Senate Majority Leader Mitch McConnell on Monday said
President Donald Trump was
completely within his rights to look into “irregularities” from last
week’s election. Paul Nolte, portfolio
manager at Kingsview Investment Management in Chicago, pinned the late session
fading on “profit-taking” after the morning rally.
The
Dow Jones Industrial Average rose 834.57 points, or 2.95%, to 29,157.97 in its
biggest one-day percentage gain since June 5. The S&P 500 rose 41.06
points, or 1.17%, to 3,550.5 and the Nasdaq Composite dropped 181.45 points, or
1.53%, to 11,713.78.
With a 14% advance the S&P energy
index led gainers among the S&P 500’s 11 major sectors and registered its
biggest daily percentage gain since March as investors bet demand would climb
again when people become more comfortable with the idea of traveling as the
health crisis subsides. Also, bank shares, often seen as a
proxy for the broader economy, soared 13% in their biggest one-day
advance since late March to hit their highest level since June.
The
companies hit hardest by months of travel bans and lockdowns surged. The NYSE airlines index closed up
19.4% while planemaker Boeing Co jumped 13.7%. Cruise line operator Carnival
Corp finished up more than 39%. In
contrast, the consumer discretionary sector was the S&P’s biggest sector
decliner with a 1.6% loss while the technology sector ended the day 0.7% lower,
pushing the Nasdaq lower for the session.
Companies that had
outperformed during the pandemic as they were seen as “stay-at-home” winners
fell sharply.
Netflix Inc fell 8.5% and Amazon.com Inc
declined 5% while Zoom Video tumbled 17.3% and exercise bike maker Peloton
Interactive Inc PTON.O> plunged 20.3% to limit the Nasdaq’s advance. “Stocks like tech are being served up as a
form of proceeds to fund the purchase of pro-cyclical stocks that would stand
to benefit from the economic reopening that could be accelerated by way of a
vaccine,” said Mark Luschini, chief investment strategist at Janney Montgomery
Scott in Philadelphia.
Stocks
around the world had already been gaining ground before the vaccine data pushed equities even higher as expectations of better global
trade ties and more monetary stimulus under U.S. President-elect Biden
was already lifting demand for risky assets. [MKTS/GLOB]
Pfizer shares closed up 7.7% after
soaring as much as 15.4% during the session. But another drugmaker Biogen Inc
slumped 28.2% as a panel of experts to the U.S. health regulator voted against
the drugmaker’s experimental Alzheimer’s treatment.
On
U.S. exchanges 17.2 billion shares changed hands in the market’s busiest trading session since
June and compared with the 9.68 billion average for the last 20 sessions.
Advancing issues outnumbered declining
ones on the NYSE by a 3.22-to-1 ratio; on Nasdaq, a 1.96-to-1 ratio favored
advancers. The S&P 500 posted 140
new 52-week highs and 1 new low; the Nasdaq Composite recorded 246 new highs
and 25 new lows.
No comments:
Post a Comment